Next 10 |
home / stock / otskf / otskf news
2024-04-30 09:30:31 ET More on Otsuka Holdings Co., Ltd. Seeking Alpha’s Quant Rating on Otsuka Holdings Co., Ltd. Historical earnings data for Otsuka Holdings Co., Ltd. Read the full article on Seeking Alpha For further details see: Otsuka Holding...
2024-04-24 09:30:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio solidly outperformed the MSCI AC World Index. Holdings in health ca...
2024-04-11 08:36:33 ET More on Alpine Immune Sciences Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug Vertex enters into agreement to acquire Alpine Immune Sciences ...
2024-01-25 15:30:27 ET Summary Vera Therapeutics, Inc. stock price soared over 35% today as it announced positive results from the open label extension of its Phase 2b ORIGIN clinical trial for atacicept in IgA nephropathy. The company's stock is up over 160% in the past year and ...
2024-01-21 13:30:00 ET Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for improved drugs in the space. Currently, the medications of choice for the condition are stimulant drugs, such as Takeda's ( NYSE: TAK ) V...
2023-11-20 11:49:37 ET Summary Intra-Cellular Therapies, Inc. is a mid-cap biopharmaceutical company focused on developing treatments for neuropsychiatric and neurological disorders. The company's commercial asset, Caplyta, has achieved significant sales growth and is an exciting ...
2023-11-20 11:18:10 ET More on Medtronic Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings Medtronic Stock Is Simply Too Cheap To Ignore Medtronic Faces Potential Decline Despite Financial Strength Medtronic Q2 2024 Earnings Preview ...
2023-11-10 10:34:03 ET More on Vera Therapeutics Vera Therapeutics' Promising Atacicept Drug Targets IgAN Guggenheim starts Vera at buy, sees IgAN drug as "well positioned" Seeking Alpha’s Quant Rating on Vera Therapeutics Historical earnings data for ...
2023-09-29 10:00:00 ET More on psychedelic drugs Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies With ecstasy a potential PTSD therapy, psychedelic treatments could take off Psychedelic Stocks = Super-Risky Biote...
2023-08-24 06:59:36 ET More on Medtronic Medtronic plc ( MDT ) Q1 2024 Earnings Call Transcript Medtronic plc 2024 Q1 - Results - Earnings Call Presentation Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Medtronic: MiniMed 780G Could Inspire G...
News, Short Squeeze, Breakout and More Instantly...
Otsuka Holdings Co. Ltd. Company Name:
OTSKF Stock Symbol:
OTCMKTS Market:
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associ...
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation i...
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE: CYBN) and UK-bas...